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Unilateral nephrectomy and 1,25-dihydroxyvitamin D3. Several renal
functions respond to nephron loss by a compensatory adaptation.
Whether the production of I ,25(OH)2D3 also adapts to a renal mass
reduction is still a matter of controversy. In the present study we have
investigated in rats the influence of unilateral nephrectomy, in both the
acute (48 hr) and chronic (2 to 6 weeks) state, on plasma I ,25(OH)2D3
level measured by competitive protein binding assay. In the acute state
no difference in plasma I ,25(OH)2D3 level between sham-operated
(SHAM) and unilateral-nephrectomized (UNI-NX) rats was found. The
presence of the thyroparathyroid glands was not required for maintain-
ing plasma l,25(OH)2D3 at a normal level 48 hr after UNI-NX. In the
chronic state in rats fed at 1.1% Ca diet, plasma l,25(OH)2D3 (5
SEM) was 94 4 in SHAM and 98 8 pM in UNI-NX. In rats fed
a 0.1% Ca diet it was 252 16 in SHAM and 239 20 pM in UNI-NX.
Analysis of 3H- 1 ,25(OH)2D3 plasma decay curve indicated that in UNI-
NX under a high calcium diet the normalization of plasma 1 ,25(OH)2D3
appears to be entirely due to an increase in production, whereas under a
low calcium diet part of it may also result from a moderate decrease in
the elimination rate. In conclusion, this study indicates that unilateral
nephrectomy does not affect the level of plasma I ,25(OH)2D3 even
under a calcium restriction challenge. This compensatory adaptation
appears to be independent of parathyroid hormone.
Uninéphrectomie et 1,25-dibydroxyvitamine D3. La diminution du
nombre de néphrons entraIne une adaptation compensatrice de plu-
sieurs fonctions rénales. Dans quelle mesure La production de Ia
1,25(OH)2D3 s'adapte a une reduction de Ia masse rénale demeure
encore une question controversée. Dans Ic present travail nous avons
étudié l'influence de Ia néphrectomie unilatérale dans sa phase aigue (48
hr) et chronique (2 a 6 semaines), sur Ia concentration plasmatique de la
I ,25(OH)2D3 déterminée par liaison competitive a une protéine. Dans Ia
phase aigue, Ic niveau plasmatique de Ia 1,25(OH)2D3 des rats uni-
nephrectomisés (UNI-NX) ne diffCrait pas de celui observe chez les
animaux pseudo-opCrCs (SHAM). Quarante-huit heures après UNI-
NX, le maintien d'un taux plasmatique de 1 ,25(OH)2D3 a un niveau
normal ne nécessitait pas la presence des glandes thyroparathyroi-
diennes. Dans Ia phase chronique sous régime riche en calcium (1.1%),
le taux plasmatique de Ia 1 ,25(OH)2D3 ( SEM) Ctait de 94 4 chez
les SHAM et 98± 8 pM chez les UNI-NX. Sous régime pauvre en
calcium (0.1%) ce mCme taux Ctait de 252 16 chez les SHAM et 239
20 pM chez les UNI-NX. L'analyse de Ia courbe de disparition
plasmatique de Ia 3H-1 ,25(OH)2D3 indiquait que chez les UNI-NX
soumis au régime riche en calcium Ia normalisation du taux plasmatique
de Ia I,25(OH)2D3 serait due entièrement a une augmentation de
production, alors que sous régime pauvre en calcium une légere
diminution de Ia vitesse d'élimination pourrait egalement y contribuer.
En rCsumé, l'Ctude présentée indique que chez le rat Ia néphrectomie
unilatCrale ne modifie pas Ic taux plasmatique de Ia I ,25(OH)2D3, même
sous régime pauvre en calcium. Cette adaptation compensatrice semble
s'effectuer independamment de l'hormone parathyroidienne.
The hormonal form of vitamin D3, 1 ,25-dihydroxyvitamin D3
[1,25(OH)2D3] is produced in the kidney by hydroxylation of
the hepatic metabolite of vitamin D3, 25-hydroxyvitamin D3
[25(OH)D3] [1—3]. For its biosynthesis under physiological
conditions, 1 ,25(OH)2D3 appears to require metabolically ac-
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tive renal tissue because patients with severe chronic renal
failure have low plasma 1,25(OH)2D3 levels [4, 5] and show
defective synthesis of this metabolite [6].
The production of 1,25(OH)2D3 is regulated in a complex
manner by parathyroid hormone (PTH), calcium (Ca), and
inorganic phosphate (Pi). l,25(OH)2D3 also seems to exert an
inhibitory effect on its own production [1, 2, 3, 7]. How the
synthesis of these metabolites is controlled in the situation of
reduced renal mass, either as a result of renal disease or
nephrectomy, is, however, unknown.
Several renal functions respond to nephron loss by a compen-
satory adaptation but whether or not the production of
1,25(OH)2D3 adapts to renal mass reduction is still a matter of
controversy. Studies in humans suggest the existence of a
compensatory adaptation in 1 ,25(OH)2D3 production in re-
sponse to renal mass reduction. Indeed, in patients with moder-
ate renal failure the plasma level of 1 ,25(OH)2D3 was not found
to be lower than in normal individuals [8—10].
However, radiotracer studies in experimental uremia pro-
duced by ureteric ligation in rats have shown reduced produc-
tion of 1,25(OH)2D3 [11, 12]. Similar studies in unilaterally
nephrectomized rats have also shown a reduced total produc-
tion of 1,25(OH)2D3 [11]. In experiments where the reduction in
nephron mass was graded by removal of different amounts of
kidney tissue the production of 1 ,25(OH)2D3 from a tracer
amount of labelled vitamin D3 decreased in proportion to the
reduction in nephron mass [13]. A criticism of these studies is
that in all cases vitamin D deficient rats were used as these are
necessary for radiotracer studies [14]. Vitamin D deficiency
itself stimulates the 25(OH)D3-1-hydroxylase to a maximum
[15], and the capacity to increase 1,25(OH)2D3 production after
unilateral nephrectomy may be lost.
Therefore, we have studied the effect of short- and long-term
unilateral nephrectomy on the plasma level and the production
of 1,25(OH)2D3 in the vitamin D repleted rat. Evidence for a
compensatory adaptation was found. The role of PTH in this
adaptation was then considered by studying the influence of
unilateral nephrectomy on plasma 1 ,25(OH)2D3 level in thyro-
parathyroidectomized rats. Finally, as a reduction in dietary Ca
increases l,25(OH)2D3 production [15] rats were given a re-
duced intake of Ca after unilateral nephrectomy to assess the
"functional reserve" of the remaining kidney.
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Methods
Male Wistar rats from our own breeding colony were used
and weighed 140 to 160 g at the beginning and around 180 g at
the end of the experiments. They were raised on a commercial
diet (Altromin 1314, Altrogge, Lage, West Germany), contain-
ing 1.1 Ca/l00 g, 1.2 P/100 g, and 250 IU vitamin D3/100 g.
During the experimental period the rats were housed individ-
ually and pairfed with diets prepared from a vitamin D poor diet
(Altromin C-1034), containing 0.14% Ca and 0.22% P to which
Ca gluconate and a mixture of NaH2PO4 and Na2HPO4 (3:7)
were added to obtain different Ca and P contents. In some
experiments the rats received vitamin D3 in 0.1 ml arachis oil
daily on the food. Prior to nephrectomy, the rats were pairfed
for 7 days with the appropriate diet. The amount of food given
each day was determined by the rat which had the lowest food
consumption.
After the equilibration period the rats were unilaterally
nephrectomized or sham-operated. Under ether anesthesia, an
incision was made in the back and the right kidney was
removed. In sham-operated rats the right kidney was manipu-
lated but otherwise left intact. The rats were then pairfed for the
periods of time stated in the acute and chronic protocols
described below. At the end of the experimental period they
were anesthetized with an intraperitoneal injection of 30 to 40
mg/kg pentobarbital (Nembutal, Abbott Laboratories, North
Chicago, Illinois) and bled by aortic puncture. Heparin was
used to prevent coagulation and plasma obtained by centrifuga-
tion was kept at —20°C until used for the measurements of
1,25(OH)2D3 and plasma phosphorus. Plasma calcium was
measured in fresh unfrozen samples.
Acute experiments. Rats were fed a diet containing 0.5% Ca
and 0.5% P and supplemented with 10 IU (625 pmoles)/day
vitamin D3. After 7 days they were unilaterally nephrectomized
or sham-operated as described above. Groups of animals were
killed 48 hr after unilateral nephrectomy and plasma levels of
calcium, Pi, 1,25(OH)2D3, and 25(OH)D3 measured as de-
scribed below.
In an additional experiment rats were equilibrated on the
0.5% Ca, 0.5% P diet, supplemented with vitamin D, as
described above. After 7 days, the animals were subjected to
surgical thyroparathyroidectomy (TPTX) or sham-operation.
Three days later plasma calcium was determined after an
overnight fast and animals having plasma levels at least 0.6
mmoles/liter lower than the mean of the sham rats were
considered to be TPTX. Thyroxine was given to the TPTX rats
by subcutaneous injection three times a week (4 g of L-
thyroxine dissolved in 0.2 ml l0- M NaOH, Fluka AG., Buchs,
Switzerland). Seven days after the TPTX or sham-operation,
half the TPTX animals were unilaterally nephrectomized
(TPTX/UNI-NX) and half were sham-operated (TPTX/SHAM).
The sham-operated animals were similarly treated (giving two
more groups SHAM/UNI-NX and SHAM/SHAM). All animals
were killed 48 hr later and blood was collected for determina-
tion of plasma Ca, Pi, and l,25(OH)2D3.
Chronic experiments. Two series of experiments were con-
ducted. In the first series plasma l,25(OH)2D3 level was deter-
mined 6 weeks after unilateral nephrectomy or sham-operation.
In the second series plasma l,25(OH)2D3 was determined 2
weeks after these operations, and evaluation of the endogenous
production of the metabolite was made by analyzing the plasma
disappearance curve of injected 3H-l ,25(OH)2D3.
First series of experiments. Rats were fed a diet containing
1.1% Ca and 0,8% P for 2 weeks supplemented with 10 IU (625
pmoles)/day vitamin D3. After this period they were unilaterally
nephrectomized or sham-operated as described above. They
were then fed the same diet for another 4 weeks. At this point,
half the sham-operated and half the UNI-NX rats were given a
diet containing 0.1% Ca and 0.8% P, while the rest still received
the diet containing 1.1% Ca and 0.8% P. After an additional 2
weeks the rats were killed and plasma levels of Ca, Pi, and
l,25(OH)2D3 were measured as described below.
Second series of experiments. Rats were fed a diet containing
1.1% Ca and 0.8% P for 1 week. After this period, they were
unilaterally nephrectomized or sham-operated as described
above. They were then fed the same diet for another week. At
this point, half the sham-operated and half the UNI-NX rats
were given a diet containing 0.1% Ca, 0.8% P while the rest
received the 1.1% Ca, 0.8% P diet. All rats received a daily
supplement of vitamin D3 (10 IU, that is, 625 pmoles) in 0.1 ml
arachis oil on the food). After another 7 days rats were either
used for the determination of plasma I ,25(OH)2D3 or given an
intravenous injection via the tail vein of 0.5 Ci (4.5 pmoles)
1 ,25[23 ,243H4](OH)2D3 (s.a. 110 Ci/mmole, Radiochemical
Centre, Amersham, Buckinghamshire, England). In this latter
group blood was collected from the tail into heparinized tubes 5
mm, 30 mm, 1, 2, 4, 8 and 15 hr after the injection. The rats
were anesthetized 30 hr after the injection and blood was
collected by aortic puncture. A lipid extract of each plasma
sample was made. The volume to be extracted was made up to I
ml with 0.9% NaCI solution (5-, 30-, 60-mm samples, 50 l
plasma, 2-, 4-, 8-, 15-hr samples, 100 d plasma, 30-hr samples,
1.0 ml plasma).
Methanol (2.5 ml) was added and each tube mixed on a vortex
mixer. Dichloromethane (5.0 ml) was then added and the mixing
procedure was repeated. The tubes were centrifuged at x 200g,
4°C, for 10 mm. The bottom layer was removed into glass
scintillation vials and the aqueous phase washed with 4.0 ml
dichloromethane. After a second 20-mm centrifugation, the
bottom layer was combined with the first organic phase and
these were evaporated to dryness. Liquid scintillation fluid (10
ml) was added and the radioactivity measured in a scintillation
counter (Packard Instruments, United Technology, Downers
Grove, Illinois), A portion of the aqueous phase (0.5 ml) was
added to 10 ml scintillator fluid. Radioactivity was also deter-
mined. No significant amount of tritium activity was found in
any of the aqueous phases. To check that the radioactivity
counted in the lipid extracts was all that of 3H-1,25(OH)2D3
several of the plasma extracts were subjected to high pressure
liquid chromatography on a Zorbax-Sil column eluted with
hexane: isopropanol 87.5:12.5 [l6J. Solvent delivery was with a
Waters 6000 A pump to give a flow rate of 1.8 mI/mm. Fractions
(30 x 0.5 mm) were collected directly into scintillation vials and
were counted for tritium activity as described. In this system
l,25(OH)2D3 elutes between 7.5 and 10.0 mm. Recovery from
the columns was 92 4% and radioactive peaks other than that
corresponding to 1 ,25(OH)2D3 were found in any of the lipid
extracts, even from the 30-hr plasma sample, contrary to the
work of other authors [17, 18]. Thus, the radioactivity found in
the extract with no chromatography was taken to be that of
1 ,25[23 ,243H4](OH)2D3 alone.
Several authors have reported substantial metabolism of
tritiated 1 ,25(OH)2D3 when injected into various animal species
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and the metabolites have been detected in both plasma and
other tissues [17, 181. Nothing but 3H-l,25(OH)2D3 was, how-
ever, detected in the plasma of our rats. Previous studies in the
rat [17] were done using vitamin D-deficient animals and a much
larger dose of 3H-l ,25(OH)2D3 (60 pmoles). The turnover of
radiolabelled vitamin D and metabolites is much faster in
vitamin D-deficient than in vitamin D-repleted animals [14], so
this, along with the larger dose of 3H-l,25(OH)2D3, could
account for the detection of metabolites of I ,25(OH)2D3 in the
earlier study [17] and not in our study. Metabolites of
I ,25(OH)2D3 have also been detected in the plasma of vitamin
D-replete calves after a dose of radiolabelled 1 ,25(OH)2D [181,
but less than 10% of the l,25(OH)2D3 is catabolized in this way.
The processing of large volumes of plasma, as possible in
calves, may allow the detection of small amounts of
1 ,25(OH)2D3 metabolites. A further possibility of discrepancy
which should be evoked concerns the tritium position on the
l,25(OH)2D3 molecule. In this work 23,24 tritiated l,25(OH)2D3
was used. Thus, hydroxylation at position "23" and/or "24"
might result in a loss of tritium, making the product undetect-
able. However, such a possibility remains unlikely because of
the high percentage of labelling at the 23 and 24 positions of the
radioactive l,25(OH)2D3 preparation used in this study.
To determine whether or not the decay of plasma
l,25(OH)2D3 obeys first order kinetics, the following experi-
ment was performed. Twelve rats were fed a diet containing
0.5% Ca and 0.5% P and were supplemented with 10 IU (625
pmoles)/day vitamin D3 for 2 weeks. They were then injected
via the tail vein with either 0.1 Ci l,25[23,243H4](OH)2D3 (0.9
pmoles, s.a, 110 Ci!mmole) or 0.1 tCi 1,25[23,243H41(OH)2D3
plus 9 pmoles unlabelled l,25(OH)2D3 (9.9 pmoles). Three rats
from each group were killed after I hr, the remaining three from
each group after 8 hr. Then blood was collected. Plasma was
extracted, analyzed by HPLC, and counted for tritium activity
as described. No metabolites of l,25(OH)2D3 were detected.
After 1 hr the rats receiving 0.9 pmole l,25(OH)2D3 had 2.05
0.12% (mean SE) of the injected dose per milliliter plasma,
whereas the group receiving 9.9 pmoles 1,25(OH)2D3 had 2.02
0.07% dose/mI. Similarly after 8 hr the percentage dose per
milliliter plasma were 1.13 0.06 and 1.21 0.06 in the 0,9
pmole and 9.9 pmoles groups, respectively. Hence, decay of
1 ,25(OH)2D3 appears to obey first order kinetics and data from
the kinetic experiments described above were analyzed as
below.
Mathematical analysis of the plasma disappearance curves
of 3H-1,25(OH)2D3. To determine the smallest number of
exponential functions which give a good fit to the data of plasma
3H-l,25(OH)2D3 the digital computer program SAAM 27 of
Berman [19] and Berman, Shahn, and Weiss [201 was used. The
goodness of the fit was estimated by a Wald-Wolfowitz test on
the number of positive and negative residuals [21]. This proce-
dure provided an acceptable fit with the residuals randomly
distributed for a two exponential curve. No improvement of fit
could be produced by adding a third exponential function.
Among the possible two-compartment models we have arbi-
trarily chosen an open model with efflux from the first compart-
ment and influx into the same initial compartment. The rate
constants were determined directly by the program, and the
sizes of the pools were calculated assuming steady state condi-
tions. The value of the first pool is uniquely determined by
extrapolating the disappearance curve to zero time and dividing
Table 1. Plasma vitamin D metabolites, calcium and phosphate levels
in rats 48 hr after unilateral nephrectomya
25(OH)D3 1 ,25(OH)2D3 Calcium Phosphate
nM pM mM mM
SHAM 25.9 2.2 135 27 2.62 0.03 3.11 0.07
N= 6
UNI-NX 23.1 1.5 117 9 2.72 0.02" 2.87 0.05bN= 7
a Experimental protocol as described in Methods under acute effect of
unilateral nephrectomy was used.
b P < 0.01 compared with SHAM animals.
the total radioactivity given to the animal by this number.
Multiplying the volume of the first pool by the mean plasma
1,25(OH)2D3 concentration will give the size of the first pool.
The turnover rate is by definition the product of the efflux rate
constant and the size of the first pool, the total exchangeable
1 ,25(OH)2D3 is defined as the sum of the two calculated pools.
Mean plasma 1 ,25(OH)2D3 levels were estimated by determin-
ing plasma 1 ,25(OH)2D3 levels in parallel groups of identically
treated rats.
Analytical methods. 1 ,25(OH)2D3' was measured by competi-
tive protein binding assays as described previously [5, 22]. In
one study plasma 25(OH)D31 was also measured by a modifica-
tion of the method of Preece et al [23].
Ca was determined by titration with EGTA using calcein (2,7
bis [bis(carboxymethyl)-amino methyl]-fluorescein, E. Merck
AG., Darmstadt, West Germany) as an indicator with a calcium
analyzer (Model 940, Corning Medical, Corning Glass Works,
Medford, Massachusetts). Plasma Pi was measured by the
micro method of Chen, Toribara, and Warner [24].
Statistical analysis. The results are expressed as means 1
SE. Students' t test was used to determine the significance of
difference between groups.
Results
Acute effect of unilateral nephrectomy. Table 1 shows the
effect of unilateral nephrectomy on plasma vitamin D metabo-
lite levels, Ca, and phosphate after 48 hr. The plasma level of
25(OH)D3 was virtually identical in both groups. Small but
significant differences in plasma Ca and phosphate were seen.
Although the mean plasma level of 1,25(OH)2D3 was slightly
lower in unilaterally nephrectomized rats, the difference was
not statistically significant.
Figure 1 shows a comparable study where the influence of
unilateral nephrectomy was studied after 48 hr in the presence
or absence of thyroparathyroid glands. As expected, thyropar-
athyroidectomized rats have slightly lower plasma 1 ,25(OH)2D3
than animals with intact parathyroid glands. In both the absence
and the presence of thyroparathyroid glands, unilateral
nephrectomy was not followed by a detectable fall in plasma
1 ,25(OH)2D3 when determined 48 hr after the reduction in the
renal mass.
Chronic effect of unilateral nephrectomy. Figure 2 shows the
'The assay procedure did not discriminate between vitamin D2 and D
metabolites. However, since the vitamin D supply of the rats was
mostly vitamin D3, the results are expressed as 25(OH)D3 and
1 ,25(OH)2D3.
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plasma levels of 1 ,25(OH)2D3 Ca and phosphate 6 weeks after
removal of one kidney or sham-operation. Half the animals
were fed a low (0.1%) calcium diet during the 2 weeks preceding
the plasma determination.
Lowering the dietary calcium to 0.1% led to a 2.5-fold
increase in the plasma levels of 1,25(OH)2D3 in both the SHAM
and UNI-NX groups (Fig. 2). Under either high or low Ca diet
there was no significant difference between SHAM and UNI-
NX in the plasma levels of l,25(OH)2D3, Ca, and Pi.
Kinetics of 1 ,25(OH)2D3 turnover in SHAM and UNI-NX
rats. Figure 3 shows the decay curves of 3H-1,25(OH)2D3 in
sham-operated or unilaterally nephrectomized rats measured 2
weeks after surgery. Half the rats of either group were fed a low
(0.1%) calcium diet during the week preceding the study, while
the remaining animals were maintained on the high (1.1%) Ca
diet. In animals fed this high Ca diet, radioactive 3H-
l,25(OH)2D3 remaining in the plasma at various times was
virtually the same in both groups, except in the last (30 hr)
blood sample where it was slightly higher in the UNI-NX than
in SHAM. In those fed the low Ca diet 3H-l,25(OH)2D3 was
found to be slightly, but consistently, higher in the UNI-NX
than in the SHAM group. Table 2 shows the production rate of
l,25(OH)2D3 and the pool sizes of l,25(OH)2D3 derived from
the analysis of the decay curve presented on Figure 2 and the
plasma level of 1 ,25(OH)2D3 determined by competitive binding
assay in parallel groups of identically treated rats. On the high
Ca diet UNI-NX animals produced 1 ,25(OH)2D3 at a slightly
slower rate than the SHAM group. The difference was not
statistically significant. On the low Ca diet the production rate
was three to four times greater than that seen in the animals fed
the high Ca diet. In this dietary condition, UNI-NX rats
produce 1 ,25(OH)2D3 at a rate significantly slower than that of
the SHAM animals (P < 0.05). In the four groups the size of the
first pool (Q) would correspond approximately to four- to
fivefold the amount of l,25(OH)2D3 contained in the plasma
volume of rats weighing 180 g.
Discussion
The results described above show that, contrary to what
would be expected from radiotracer studies in vitamin D-
depleted animals [11, 13], unilateral nephrectomy does not
300
200
100
DietCa% 1.1 0.1 1.1 0.1
Plasma Ca, mM SEM 2.54±0.02 2.42±0.04 2.43±0.03 2.57±0.04
Plasma Pi, mM SEM 2.40±0.04 2,21 2.21 ±0.09
Numberofanimals 16 16 14 12
Fig. 2.Plasma level of 1,25(OH)2D3 6 weeks after unilateral nephrecto-
my in rats fed either high or low calcium diet. Abbreviations are: UNI-
NX, unilateral nephrectomy; SHAM, sham-operated.
result in a significant fall in the plasma levels of l,25(OH)2D3.
Van Stone, Frank, and Bradford [11] reported a 50% drop in
the production of 1 ,25(OH)2D3 4 hr after UNI-NX of vitamin D-
deficient rats without improvement 4 weeks after surgery. In
our experiments, carried out in vitamin D-repleted rats, by 48 hr
after UNI-NX, a fall in the plasma level of 1 ,25(OH)2D3 was not
seen. In view of the rather fast decay of l,25(OH)2D3 (Fig. 3)
one might expect a significant fall in plasma 1 ,25(OH)2D3 48 hr
after UNI-NX in the absence of any compensatory mechanism.
Such a fall does not occur (Table 1), indicating a compensatory
mechanism which operates quickly after UNI-NX. As expected
[25—281 the plasma level of 1 ,25(OH)2D3 seemed to be lower in
TPTX rats than in their counterparts with intact parathyroid
glands. Nevertheless, in animals without a reduced renal mass
the fall in plasma 1 ,25(OH)2D3 in response to TPTX was less
impressive than that reported in a previous study, using the
same methodology for determining the vitamin D metabolite
[28]. The reason for this difference in the response to TPTX is
not clear. In the absence of parathyroid glands both the Pi [27,
29] and Ca [28] status can still markedly affect the production
and plasma level of 1 ,25(OH)2D3. Therefore, the magnitude of
the difference in plasma 1 ,25(OH)2D3 between intact and TPTX
animals will depend upon their Pi and Ca status. The fact that in
our study in UNI-NX animals the influence of TPTX was still
more modest than in animals with intact renal mass might also
be related to the fact that the inhibitory influence of PTH
deficiency on 1 ,25(OH)2D3 can be counteracted by other regu-
lating factors. Whatever the reason for the modest effect of
TPTX observed in this study, the present investigation shows
that the effect of UNI-NX is the same in TPTX as in intact
animals (Fig. 1). Thus, the apparent compensation does not
require the presence of parathyroid hormone. Furthermore, our
results indicate that 6 weeks after unilateral nephrectomy
lowering dietary calcium from 1.0 to 0.1% results in a rise in
plasma 1 ,25(OH)2D3 similar to that observed in animals with
intact renal mass.
Kinetic studies of the turnover of radioactively labelled
l,25(OH)2D3 show that in UNI-NX rats fed a high Ca diet
(1.1%) the production and the individual and total exchangeable
pool sizes of l,25(OH)2D3 are almost totally compensated
(Table 2). In UNI-NX rats fed a low Ca diet (0.1%), the pool
sizes are compensated. However, the compensation is not
complete for the production of 1 ,25(OH)2D3 is significantly
lower than in the SHAM rats. Thus, part of the normalization of
the plasma level of 1 ,25(OH)2D3 under the condition of calcium
Kidney
c
I(no +
C'1
TPTX SHAM UNI-NX
Plasma Ca, mM SEM 2.79±0.04 3.00±0.05
Plasma Pi, mM SEM 2.45±0.05 2.36±0.06
Number of animals 5 6
2.17±0.06 2.15±0.11
3.03±0.09 3.03±0.21
8 8
Fig. 1. Plasma level of 1,25(OH)2D3 48 hr after unilateral nephrectomy
in rats with intact parathyroid glands or thyroparathyroidectomized.
Abbreviations are: TPTX, thyroparathyroidectomy; UNI-NX, unilater-
al nephrectomy; SHAM, sham-operated.
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Table 2. Plasma concentration, production rate, and pool sizes of I ,25(OH)2D3 in sham-operated and unilaterally nephrectomized rats fed diets
containing different calcium contentsa
Plasma
concen-
tration
Production Individual pools
Q1 Q2
Total ex-
change-
able pool
Rate constants
pmoles/kg K21 K12 K01
Diet pM pmoleslhour b.w./day pmoles pmoles pmoles min mm' min
94 4 0.251 0.019 33.5 2.5
SHAM, N = 4
2.2 0.2 3.4 0.2 5.6 0.2 1.40 0.19 0.92 0.08 0.111 0.004
1.1% Ca
0.8% P
98 8 0.216 0.003 28.8 0.4
UNI-NX, N = 4
2.3 0.2 3.9 0.2 6.2 0.4 1.43 0.21 0.80 0.09 0.098 0.007
252 16 0.832 0.055 110.9 7.3
SHAM, N = 4
6.1 0.4 10.3 0.8 16.4 0.7 1.80 0.27 1.08 0.11 0.138 0.012
0.1% Ca
0.8% P
239 20 0.592 0.062b 78.9 8.3b
UNI-NX, N = 4
5.6 0.3 9.4 0.6 15.0 0.6 1.31 0.13 0.80 0.14 0.105 0.005b
Abbreviations: Qi and Q2, amount of 1 ,25(OH)2D3 contained in compartment 1 and 2, respectively; K21, constant rate transfer from Q to Q2;
K12, constant rate transfer from Q2 to Q; K01, constant rate transfer from Q to the outside system.
a Sham-operation or unilateral nephrectomy was made 2 weeks before determination of 3H- 1 ,25(OH)2D3 plasma decay curve (see Fig. 3) and
plasma level of 1 ,25(OH)2D3. The low (0.1%) calcium diet was given 1 week before the study. Values are calculated using the two-compartmental
kinetic model as described in Methods. Compartmental analysis was done of the plasma disappearance of 3H-l ,25(OH)2D3 in sham-operated or
unilaterally nephrectomized rats fed diets of differing Ca content.
b P < 0.05 compared with SHAM animals.
restriction could be due to some decrease in the metabolic
elimination of the hormone.
With regard to the production rates of 1,25(OH)2D3 it is of
interest to compare our data with information published so far.
Using computer models, the daily production of 1 ,25(OH)2D3 in
humans has been calculated to be around 20 pmoles/kg body
weight [30]. Ogura et al [311 calculated the daily turnover of
l,25(OH)2D3 in the dog after 60% renal mass reduction as 18
pmoles/kg body weight/day and also reported that plasma levels
of this metabolite were normal in these animals. Taking the
mean body weight of all the rats at the end of the experiments
_________________________________
described here as 180 g, the production of 1,25(OH)2D3 in
pmoles/kg body weight/day can be calculated from the turnover
of radioactively labelled 1,25(OH)2D3 (Table 2). The SHAM
and UNI-NX animals fed the 1.1% Ca diet which had plasma
l,25(OH)2D3 levels of 93.5 4.2 and 98.2 7.8 p, respective-
ly, produced 33.5 2.5 and 28.8 0.4 pmoles/kg body
weight/day 1 ,25(OH)2D3, respectively. In a recent paper by
Maierhofer et al [32] the turnover of radioactively labelled
1 ,25(OH)2D3 in humans with different plasma 1 ,25(OH)2D3
levels is reported. In two normal subjects with plasma
1,25(OH)2D3 levels of 84 and 76 p, daily production of
l,25(OH)2D3 was calculated as 34 and 32 pmoles/kg body
weight [32]. These results correspond exactly with those in the
rat described above. Similarly in patients with higher plasma
1 ,25(OH)2D3 as a result of hyperparathyroidism or hypercal-
____________________________________
ciuria, daily production of l,25(OH)2D3 is reported as being
higher. These situations can be compared with the rats fed the
low Ca diet which have higher plasma levels and a higher renal
production of 1 ,25(OH)2D3.
In summary, the production of the renal metabolite of vitamin
D3, l,25(OH)2D3, responds to nephron loss by a compensatory
adaptation which results in a completely normal state. This
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Fig. 3. Decay curves of 1,25[23,243HJ(OH)2D3 2 weeks after unilateral
nephrectomy or sham-operation in rats fed either 0.1% or 1.1% Ca diet.
Each point represents the mean of four rats in each group. The SEM are
not drawn. They were less than 10% of the mean for all the determina-
tions. Symbols are: •, SHAM; , UNI-NX.
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compensation appears to occur relatively fast as no significant
reduction in the plasma concentration of this metabolite can be
detected 48 hr after UNI-NX. The daily production of
1 ,25(OH)2D3 in the rat calculated from the turnover of radioac-
tively labelled material and measurement of plasma
l,25(OH)2D3 by competitive protein binding assay corresponds
well with both the computer calculated and experimentally
measured rate in humans and also that in the dog.
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